Navigation Links
Benign eye tumors being treated

Researchers at the University of Texas feel that they may have found an effective treatment for a type of non-cancerous eye tumor that threatens clear vision.// Using photodynamic therapy, researchers successfully restored vision in three patients who were suffering from intraocular choroidal hemangiomas, which involved serious retinal detachments.

Intraocular choroidal hemangiomas are benign tumors, which can cause symptoms due to their location, growth, and the accumulation of fluid in the eye. Doctors generally don't treat the tumors unless the problems lead to vision loss or a detached retina.

In these cases, each of the patients was suffering from a tumor in one eye, and all suffered loss of vision and a detached retina. In the first case, a 60 year old man attempted reatment after experiencing decreased visual acuity in his right eye for two weeks. In the second case, a 40 year old man came to the clinic complaining of flickering lights and decreased visual acuity in his left eye. The third subject was a 65 year old man who had been initially diagnosed in 1995 and followed for the next 5 years, during which time he began to experience significantly worsening vision and an expanding central blind spot.

Researchers used photodynamic therapy to treat the detached retinas and shrink the tumors. Photodynamic therapy includes a light-sensitive dye that produces blood clots to terminate the growth of abnormal new blood vessels. In all three cases, the therapy resolved the detached retinas and shrunk the tumors beyond measurable size. Vision improved to 20/20 for the first two patients and to 20/200 for the third patient. After 10 months to 15 months of follow-up, none of the tumors had returned. Researchers conclude photodynamic therapy appears to be effective for the treatment of choroidal hemangioma.


'"/>




Page: 1

Related medicine news :

1. New Technique For Benign Breast Tumors
2. Another Treatment Option for Benign Tumors
3. ‘Benign’ MS May Not Be So Benin
4. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
5. Morphine may excite cancerous tumors
6. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
7. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Same molecule found in meat, milk, tumors
10. Women with borderline ovarian tumors can still preserve their fertility
11. Surgery to remove tumors in the spine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... , ... May 31, 2016 , ... Phynd Technologies, Inc. ... GA; Houston Methodist – Houston, TX and Shore Medical Center – Somers Point, NJ. ... three different, leading EHR solutions, demonstrating the breadth of Phynd’s solution and its interoperability. ...
(Date:5/31/2016)... ... , ... In a recent interview on The Greenburgh Report radio show hosted ... WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross discussed several eye-opening ... maelstrom.” , During the interview with Mr. Feiner that aired on May 7, ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/31/2016)... ... May 31, 2016 , ... Super Powder, a supplement produced ... the go individuals and dedicated athletes, continues to transform the nutritional supplement industry by ... pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, digestive enzymes, ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... , May 30, 2016 ... titled, "Advanced (3D/4D) Visualization Systems Market - Global Industry ... 2024." According to the report, the global advanced (3D/4D) ... in 2015 and is anticipated to expand at a ... US$ 3.2 Bn in 2024. Advanced (3D/4D) ...
(Date:5/30/2016)... -- - DCGI grants limited approval to market Stempeucel® ... - Stempeucel® becomes 5th off-the-shelf Stem cell product to be ... - Buerger,s Disease (also known as Thromboangiitis Obliterans) is a major ... - Prevalence of Buerger,s Disease is estimated to be ... persons in the European Community & USA ...
(Date:5/27/2016)... PUNE, India , May 27, 2016 ... in the instances of hypertension is driving ambulatory blood ... muscles lose their elasticity and their ability to respond ... blood pressure. This condition can lead to various cardiovascular ... and peripheral vascular disease. These diseases are growing in ...
Breaking Medicine Technology: